Although the role of MD2 in hyperglycemia-induced cardiac inflammatory injury is unknown, these evidences point to the intriguing possibility that glucose or glucose-derived factors interact with MD2 to activate TLR4. This evidence concerns the gene LY96 and Hyperglycemia.